Molecular Beacon Assay Development for Severe Acute Respiratory Syndrome Coronavirus 2 Detection

• Autor(a) principal: Carvalho, Josué
• Data de Publicação: 2021
• Outros Autores: Nunes, J. Lopes, Figueiredo, Joana, Santos, Tiago, Miranda, André, Riscado, Micaela, Sousa, Fani, Duarte, A. P., Socorro, Sílvia, Tomaz, Cândida, Felgueiras, Mafalda, Teixeira, Rui, Faria, Conceição, Cruz, Carla
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: http://hdl.handle.net/10400.6/11930
• topic: RNA viruses; SARS-CoV-2; COVID-19; Fluorescence detection; Diagnosis

The fast spread of SARS-CoV-2 has led to a global pandemic, calling for fast and accurate assays to allow infection diagnosis and prevention of transmission. We aimed to develop a molecular beacon (MB)-based detection assay for SARS-CoV-2, designed to detect the ORF1ab and S genes, proposing a two-stage COVID-19 testing strategy. The novelty of this work lies in the design and optimization of two MBs for detection of SARS-CoV-2, namely, concentration, fluorescence plateaus of hybridization, reaction temperature and real-time results. We also identify putative G-quadruplex (G4) regions in the genome of SARS-CoV-2. A total of 458 nasopharyngeal and throat swab samples (426 positive and 32 negative) were tested with the MB assay and the fluorescence levels compared with the cycle threshold (Ct) values obtained from a commercial RT-PCR test in terms of test duration, sensitivity, and specificity. Our results show that the samples with higher fluorescence levels correspond to those with low Ct values, suggesting a correlation between viral load and increased MB fluorescence. The proposed assay represents a fast (total duration of 2 h 20 min including amplification and fluorescence reading stages) and simple way of detecting SARS-CoV-2 in clinical samples from the upper respiratory tract.